IDEA #2BRORG ABANDONED, per CSMC 20190826 3:02 PM email to N Mitra. Using Dual GLP-1/GIP Receptor Agonists To Treat Brain Insulin Resistance, Mild Cognitive Impairment and Alzheimer's Disease Dementia

For more information or to license this innovation: